Literature DB >> 10415023

Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase.

H Kitagaki1, M Kimishima, Y Teraki, J Hayakawa, K Hayakawa, S Fujisawa, T Shiohara.   

Abstract

Although regional lymph nodes (LN) have been extensively studied as rich sources of effector T cells in contact hypersensitivity (CH), it remains unknown whether T cell responses in the LN reflect those in effector skin sites. We previously showed that repeated elicitation of CH results in a shift in the time course of Ag-specific CH from a delayed-type hypersensitivity response to an early-type response, a reflection of a shift in cutaneous cytokine expression from a type 1 to a type 2 profile. To investigate whether repeated elicitation of CH could also drive T cell development to the type 2 phenotype in the regional draining LN, sequential cytokine gene expression after hapten application was assessed during both the acute and the chronic phase of CH. In the draining LN the shift to type 2 cytokine production was also observed, but more mixed patterns of responses were induced than in the corresponding skin sites. The chronic LN cells (LNC), when stimulated in vitro, produced markedly lower levels of type 1 cytokines and higher levels of type 2 cytokines than the acute LNC. A successful passive transfer of an early-type response by the LNC was only induced in the recipient mice when the skin sites chronically treated with hapten were elicited. These results indicate that an early-type response by regional LNC would take place only in a milieu with sufficient levels of type 2 cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415023

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses.

Authors:  Tomoyuki Fujita; Manabu Fujimoto; Takashi Matsushita; Yuka Shimada; Minoru Hasegawa; Yoshihiro Kuwano; Fumihide Ogawa; Kazuhiko Takehara; Shinichi Sato
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

2.  Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis.

Authors:  Manisha S Lalan; Naresh C Laddha; Jigar Lalani; Muhammad J Imran; Rasheedunnisa Begum; Ambikanandan Misra
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

3.  Phthalate ester-induced thymic stromal lymphopoietin mediates allergic dermatitis in mice.

Authors:  Tomomi Shigeno; Mayako Katakuse; Tomoyuki Fujita; Yohei Mukoyama; Hideki Watanabe
Journal:  Immunology       Date:  2009-03-23       Impact factor: 7.397

4.  Aberrant production of Th1/Th2/Th17-related cytokines in serum of C57BL/6 mice after short-term formaldehyde exposure.

Authors:  Haiyan Wei; Kehong Tan; Rongli Sun; Lihong Yin; Juan Zhang; Yuepu Pu
Journal:  Int J Environ Res Public Health       Date:  2014-09-26       Impact factor: 3.390

5.  A murine model of atopic dermatitis can be generated by painting the dorsal skin with hapten twice 14 days apart.

Authors:  Ayaka Kitamura; Ryohei Takata; Shin Aizawa; Hajime Watanabe; Tadashi Wada
Journal:  Sci Rep       Date:  2018-04-16       Impact factor: 4.379

6.  Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice.

Authors:  Aki Nakamura; Hideya Uratsuji; Yoshihito Yamada; Kei Hashimoto; Naoki Nozawa; Tatsumi Matsumoto
Journal:  Mycoses       Date:  2019-11-27       Impact factor: 4.377

7.  Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation.

Authors:  Yoshiko Mizukawa; Takaaki Doi; Yoshimi Yamazaki; Akihiko Kudo; Tetsuo Shiohara
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.